Literature DB >> 22740093

Metabolic syndrome between two ethnic minority groups (Circassians and Chechens) and the original inhabitants of Jordan.

Rana Dajani1, Yousef S Khader, Nancy Hakooz, Raja Fatahalla, Farouk Quadan.   

Abstract

The prevalence of metabolic syndrome is increasing worldwide and exhibits variation among ethnic groups. The objective of this study was to estimate and compare the prevalence of metabolic syndrome and its components between two ethnic groups (Circassians and Chechens) in Jordan and the original inhabitants of Jordan. Data were collected from a cross-sectional study of Circassian (n = 436), Chechen (n = 355), and Jordanian (n = 3234) population aged 18 years and older. Metabolic syndrome was defined according to International Diabetes Federation criteria. Age-standardized prevalence rate of metabolic syndrome was Jordanians 38.0 %, Circassians 32.0 %, and Chechens 33.7 %. Compared to Jordanians, both minority groups had lower means of body mass index, total cholesterol, fasting blood glucose, and triglycerides. The means of high-density lipoprotein and low-density lipoprotein were significantly higher among Circassians compared to Jordanians and Chechens. The odds of BMI defined by overweight and obesity and diabetes were less common among Circassians and Chechens compared to Jordanians. The prevalence of the metabolic syndrome and its individual components is relatively high in the three ethnic groups compared to world. Variation in components between groups may relate to ethnicity. Therefore, a community-based integrated approach is needed that would include behavioral, social changes that would lead to the prevention and treatment of the metabolic syndrome.

Entities:  

Mesh:

Year:  2012        PMID: 22740093     DOI: 10.1007/s12020-012-9723-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  20 in total

1.  Factor analysis of modifiable cardiovascular risk factors and prevalence of metabolic syndrome in adult Taiwanese.

Authors:  Chung-Huang Tsai; Tsai-Chung Li; Cheng-Chieh Lin; Hsin-Sheng Tsay
Journal:  Endocrine       Date:  2011-04-16       Impact factor: 3.633

2.  Prevalence of dyslipidemia and its associated factors among Jordanian adults.

Authors:  Yousef S Khader; Anwar Batieha; Mohammed El-Khateeb; Mousa Al Omari; Kamel Ajlouni
Journal:  J Clin Lipidol       Date:  2009-12-22       Impact factor: 4.766

3.  Genetic diversity in the Caucasus.

Authors:  G Barbujani; I S Nasidze; G N Whitehead
Journal:  Hum Biol       Date:  1994-08       Impact factor: 0.553

4.  The metabolic syndrome in the West Bank population: an urban-rural comparison.

Authors:  H F Abdul-Rahim; A Husseini; E Bjertness; R Giacaman; N H Gordon; J Jervell
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

5.  The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Yong-Woo Park; Shankuan Zhu; Latha Palaniappan; Stanley Heshka; Mercedes R Carnethon; Steven B Heymsfield
Journal:  Arch Intern Med       Date:  2003-02-24

6.  Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome.

Authors:  Darcy B Carr; Kristina M Utzschneider; Rebecca L Hull; Keiichi Kodama; Barbara M Retzlaff; John D Brunzell; Jane B Shofer; Brian E Fish; Robert H Knopp; Steven E Kahn
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

7.  An increase in prevalence of diabetes mellitus in Jordan over 10 years.

Authors:  Kamel Ajlouni; Yousef S Khader; Anwar Batieha; Haitham Ajlouni; Mohammed El-Khateeb
Journal:  J Diabetes Complications       Date:  2008-04-16       Impact factor: 2.852

8.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

9.  The prevalence of the metabolic syndrome among arab americans.

Authors:  Linda A Jaber; Morton B Brown; Adnan Hammad; Qian Zhu; William H Herman
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

10.  Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan.

Authors:  Fayzeh M Mubarak; Erika S Froelicher; Hashem Y Jaddou; Kamel M Ajlouni
Journal:  Ann Saudi Med       Date:  2008 Sep-Oct       Impact factor: 1.526

View more
  4 in total

1.  Association of hematological parameters with metabolic syndrome in Beijing adult population: a longitudinal study.

Authors:  Li-Xin Tao; Xia Li; Hui-Ping Zhu; Da Huo; Tao Zhou; Lei Pan; Yan-Xia Luo; Wei Wang; Zhao-Ping Wang; Dong-Ning Chen; Li-Juan Wu; Xiu-Hua Guo
Journal:  Endocrine       Date:  2013-10-04       Impact factor: 3.633

2.  Hypertension Prevalence, Awareness and Control Levels among Ghawarna: An African-Descendant Ethnic Minority in the Jordan Valley.

Authors:  Khalid A Kheirallah; Mohammed Liswi; Rami Alazab; Zeyad Bataineh; Sukaina Alzyoud; Jomana Alsulaiman; Hashem Jaddou
Journal:  Ethn Dis       Date:  2015-08-07       Impact factor: 1.847

3.  Diabetes mellitus in two genetically distinct populations in Jordan. A Comparison between Arabs and Circassians/Chechens Living with Diabetes.

Authors:  Laith N Al-Eitan; Ahmad M Nassar; Rana B Dajani; Basima A Almomani; Nesreen A Saadeh
Journal:  Saudi Med J       Date:  2017-02       Impact factor: 1.484

4.  Effect of age on the phenotype of metabolic syndrome in developing country.

Authors:  Mojgan Gharipour; Masoumeh Sadeghi; Mohsen Hosseini; Elham Andalib; Maraym Bakhtiari Boroujeni; Nizal Sarrafzadegan
Journal:  Adv Biomed Res       Date:  2015-05-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.